Details for Patent: 8,607,785

Which drugs does patent 8,607,785 protect, and when does it expire?

Patent 8,607,785 protects GENOSYL and is included in one NDA.

This patent has eight patent family members in five countries.

Summary for Patent: 8,607,785

Title:	Systems and devices for generating nitric oxide
Abstract:	Various systems and devices for generating nitric oxide are disclosed herein. According to one embodiment, the device includes a body having an inlet, an outlet, and a porous solid matrix positioned with the body. The porous solid matrix is coated with an aqueous solution of an antioxidant, wherein the inlet is configured to receive a gas flow and fluidly communicate the gas flow to the outlet through the solid matrix to convert nitrogen dioxide in the gas flow into nitric oxide. The porous solid matrix allows the device to be used in any orientation. Additionally, the porous solid matrix provides a rigid structure suitable to withstand vibrations and abuse without compromising device functionality.
Inventor(s):	David H. Fine, Bryan Johnson, Gregory Vasquez
Assignee:	Vero Biotech Inc
Application Number:	US12/541,137
Patent Claim Types: see list of patent claims	Compound; Delivery; Device;

Drugs Protected by US Patent 8,607,785

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Vero Biotech Inc	GENOSYL	nitric oxide	GAS;INHALATION	202860-001	Dec 20, 2019		RX	Yes	Yes			Y

International Family Members for US Patent 8,607,785

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2009282986
Canada	2734788
European Patent Office	2328592
Japan	2012500091